SCHEMBL6959185

SCHEMBL6959185

Fc1ccc2c(c1)CC(n1c(F)c[nH]c1=S)CC2

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 4/20 0.39
HTR2C P28335 3/20 0.39
DRD2 P14416 2/20 0.37
HTR2A P28223 2/20 0.37
HTR1D P28221 1/20 0.34
HTR1B P28222 1/20 0.34
SLC6A4 P31645 2/20 0.33
HTR1A P08908 1/20 0.33
HTR7 P34969 1/20 0.33
DRD3 P35462 1/20 0.33
SRD5A1 P18405 4/20 0.31
ADRA2A P08913 1/20 0.31
ADRA2B P18089 1/20 0.31
ADRA2C P18825 1/20 0.31
HDAC8 Q9BY41 2/20 0.31
TDP1 Q9NUW8 1/20 0.31
CTSD P07339 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8807404 0.85 HTR2B (0.34) HTR2BHTR2CDRD2HTR2AHTR1D
SCHEMBL6952484 0.85 HTR2C (0.37) HTR2BHTR2CDRD2HTR2AHTR1D
SCHEMBL6958877 0.85 TDP1 (0.45) HTR2BHTR2CDRD2HTR2AHDAC8
SCHEMBL6952490 0.85 HTR2C (0.37) HTR2BHTR2CDRD2HTR2AHTR1D
SCHEMBL8807409 0.85 HTR2B (0.34) HTR2BHTR2CDRD2HTR2AHTR1D
Hydrochloric Acid SCHEMBL6947031 0.84 HTR2B (0.34) HTR2BHTR2CDRD2HTR2AHTR1D
Hydrochloric Acid SCHEMBL6947036 0.84 HTR2B (0.34) HTR2BHTR2CDRD2HTR2AHTR1D
SCHEMBL6958615 0.80 HTR2C (0.37) HTR2BHTR2CDRD2HTR2AHTR1D
SCHEMBL8806447 0.80 HTR1D (0.38) HTR2BHTR2CDRD2HTR2AHTR1D
SCHEMBL6958622 0.80 HTR2C (0.37) HTR2BHTR2CDRD2HTR2AHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0757677-B1 BENZOCYCLOHEXYLIMIDAZOLETHIONE DERIVATIVES SYNTEX LLC (US) 2003-06-18 EP disclosed
US-5719280-A REACTING AMINE SUBSTITUTED BENZOCYCLOALKANE WITH DIALKYLOXYACETALDEHYDE IN PRESENCE OF REDUCING AGENT OR CATALYTIC HYDROGENATION, TREATING WITH THIOCYANIC ACID SYNTEX (U.S.A.) INC. (US) 1998-02-17 US disclosed
EP-0757677-A1 BENZOCYCLOALKYLAZOLETHIONE DERIVATIVES SYNTEX (U.S.A.) INC. (US) 1997-02-12 EP disclosed
US-5538988-A CARDIOVASCULAR DISORDERS AND DOPAMINE HYDROLASE ENZYME INHIBITORS SYNTEX (U.S.A.) INC. 1996-07-23 US disclosed
WO-1995029165-A2 BENZOCYCLOALKYLAZ0LETHIONE DERIVATIVES AS DOPAMIN BETA-HYDROXYLASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1995-11-02 WO disclosed